Technology ID
TAB-4622
DENV-2, 1710 as a Cancer Therapeutic
E-Numbers
E-030-2016-0
Lead Inventor
Gubler, Duane
Lead IC
CDC
Applications
Vaccines
Therapeutics
Therapeutic Areas
Oncology
Development Stages
Pre-Clinical (in vitro)
This technology includes a Dengue-2 isolated virus for use as a cancer vaccine therapeutic.
Commercial Applications
Therapeutic cancer vaccine.
Competitive Advantages
Unmodified strain of the virus is being utilized.
Licensing Contact: